Rovers Medical Devices

Name

Rovers Medical Devices

Legal name

Rovers Medical Devices B.V.

Website

https://roversmedicaldevices.com

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Cancer Screening Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

akta.pro secondary industries

Oral Cancer Screening (HLABAHAF), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Cell sampling devices
• Cervical cancer screening
• HPV self-sampling
• Medical device manufacturing
• Cancer diagnostics

Headquarters

HQ city

Oss

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Rovers Medical Devices designs, develops, manufactures, and markets cell sampling devices for cancer screening. The company sells its products (brushes, samplers, and accessories) to healthcare providers, national screening programs, hospitals, and laboratories globally. Revenue is generated through direct sales and distribution partnerships.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Rovers Medical Devices designs, develops, and manufactures single-use cell sampling medical devices used in cancer screening. Its portfolio includes brushes for cervical (Cervex-Brush family, EndoCervex-Brush), oral (Orcellex Brush), and anal (Anex Brush) cancer screening, along with self-sampling devices (Evalyn Brush, Viba-Brush) for HPV testing, plus accessories such as the Remover Tube. Devices are sold to hospitals, laboratories, HMOs, and national cervical cancer screening programs across more than 50 countries.

Product overview

Rovers Medical Devices is a designer and manufacturer of cell sampling medical devices for cancer screening applications. The product portfolio includes cervical cancer screening devices (Cervex-Brush, Cervex-Brush Combi, EndoCervex-Brush, EndoCervex-Brush-S), oral cancer screening (Orcellex Brush), anal cancer screening (Anex Brush), and self-sampling solutions (Evalyn Brush, Viba-Brush). All devices are based on proprietary fine bristle technology with soft, flexible hairs for optimal sample collection without tissue damage. The products support cytological analysis, liquid-based cytology, HPV testing, bacteriological testing, viral testing, and DNA analysis. The company also offers accessories including the Remover Tube for contamination-free sample processing.

Differentiator

Problem solved

Functional benefit

Brands

• Cervex-Brush: Cervical cancer screening device with semi-circular soft, flexible hairs for optimal sample collection, enabling simultaneous collection of ectocervical, endocervical and transformation-zone cells.
• Evalyn Brush
• Viba-Brush
• Orcellex Brush
• Anex Brush
• EndoCervex-Brush

Products and services

• Cervex-Brush The most widely used cervical cancer screening device, with semi-circular soft, flexible hairs that enable simultaneous collection of ectocervical, endocervical, and transformation-zone cells for cytology and HPV testing. Marketed to clinicians and national cervical cancer screening programs.
• Cervex-Brush Combi Cervical cancer screening device that simultaneously collects ectocervical, endocervical, and transformation-zone cells, collecting 2-3 times more endocervical cells and showing significantly higher HPV viral load than standard samplers. Used by clinicians and screening programs for cytology and HPV workflows.
• EndoCervex-Brush Endocervical sampler with an integrated protective tip and 600 soft, flexible bristles designed for optimal endocervical sampling with reduced tissue damage. Targeted at gynecologists and diagnostic laboratories performing endocervical cytology.
• EndoCervex-Brush-S Small endocervical brush with over 246 soft, flexible bristles, developed specifically for endocervical sampling when the entrance of the endocervical canal is narrow or stenotic. Marketed to clinicians performing targeted endocervical cytology.
• Orcellex Brush Oral cancer screening device that enables easy collection of cells from all layers of the oral epithelium, achieving on average 55,000 cells per slide with liquid-based cytology and supporting PCR testing. Used by dentists, oral surgeons, and OraLiva's AI-powered oral cancer screening service.
• Anex Brush Anal cancer screening device that samples the entire anal canal including the anal transformation zone without requiring a proctoscope or anoscope, providing a single sample for HPV testing, cytology, and protein testing. Marketed to HIV clinics and specialized screening programs for high-risk populations.
• Viba-Brush Economic self-sampling device for HPV testing, designed for low- and middle-income countries using flexible bristle technology with high concordance for CIN 3+ and CIN 2+ based on hrHPV positivity. Used in cervical cancer screening campaigns such as the Rwanda Biomedical Center program in Bugesera district.
• Evalyn Brush Self-sampling device for HPV cervical cancer screening, designed for women to collect vaginal/cervical specimens at home; features insertion indicator wings and click feedback to ensure correct sample taking and an integrated RFID chip for sample identification. Selected by the Dutch and Danish national cervical screening programs and used by Mayo Clinic for HPV self-collection in the United States.
• Delphi Screener Legacy cervical self-sampling device using a unique lavage method designed for the anatomy of the vagina with no risk of breakage; now discontinued in favor of the Evalyn Brush but retained on the company website for reference.
• Remover Tube Accessory tube with an inbuilt automatic stop that detaches the brush head while the tube stays on the handle, enabling contamination-free brush detachment for PCR and other sensitive diagnostic test methods. Sold to diagnostic laboratories and HPV testing workflows.

Quantifiable outcome

• 99.69% valid sample rate demonstrated in large-scale Danish screening implementation
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• OraLivacoreStrategic or Co-development Partner · 3 March 2026Collaboration announced March 2026 for new clinical application of Rovers' patented Orcellex brush in OraLiva's AI-powered oral cancer screening test. The test leverages cytological risk assessment for early detection of oral cancer using proprietary algorithms evaluating nuclear morphology, biomarker expression, and cellular phenotype frequencies.
• Mayo CliniccoreImplementation/ SI/ Consulting Partner · 5 February 2025Mayo Clinic introduced HPV self-collection services using Evalyn Brush starting February 2025. The world's No. 1 hospital (per Newsweek) announced availability at Mayo Clinic practices in the Midwest, expanding to Arizona and Florida. This supports improved cervical cancer screening access.
• HealthtrackacoreStrategic or Co-development Partner · 31 October 2023Partnership launched October 2023 to provide HPV testing services in Nigeria using the Evalyn Brush. Healthtracka, a Lagos-based healthcare diagnostics company, offers advanced HPV testing with accessible testing at healthcare centers. Uber partnered with Healthtracka providing HPV Self-Sampling Kits to female drivers.
• BIO Ventures for Global Health (BVGH)minorStrategic or Co-development Partner · 10 September 2021Cooperation to supply screening devices to Rwanda Biomedical Center for cervical cancer screening campaign in Bugesera district. The campaign targets women aged 30-49 and uses Viba-Brush for HPV testing in local laboratories.
• Maccabi HMO (Israel)minorChannel Partner/ Reseller/ Distributor · 30 June 2021Conducted pilot with Evalyn Brush for women who had not been tested for cervical cancer for more than three years. 7 out of 100 participants diagnosed HPV positive. Implementation through local partner Gamidor Diagnostics.
• Gamidor Diagnostics (Israel)minorChannel Partner/ Reseller/ Distributor · 30 June 2021Local distribution partner in Israel responsible for distributing Evalyn Brush and implementing HPV self-sampling programs with Maccabi HMO and other Israeli healthcare organizations.
• FSB (Collaboration Facility Population Screening, Netherlands)coreChannel Partner/ Reseller/ Distributor · 9 December 2015Awarded 5-year contract by FSB for supply of Evalyn Brush self-collection sets for hrHPV testing for non-responders to the Netherlands national cervical cancer screening program. Non-responders account for over 50% of all cervical cancer cases in Netherlands.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Becton Dickinson (BD): Diversified medical technology company with BD Diagnostic Systems, including the SurePath cervical cancer screening platform. Competes in the same cervical screening workflow at much greater scale.
• CooperSurgical: Women's health and reproductive medicine device company (Wallach surgical instruments, fertility, OB/GYN). Operates in the same physician office and screening workflows as Rovers' brushes.
• Hologic: US diagnostics leader with ThinPrep Pap Test and extensive women's health/cervical cancer screening franchise. Vertically integrated competitor spanning collection through molecular diagnostics; broader portfolio than Rovers.
• Qiagen: Global molecular diagnostics provider with HPV testing products (e.g., digene HC2) and sample-preparation technologies. Adjacent to Rovers as the downstream assay provider often paired with collection devices.

Direct peers

• Femasys: US women's health medical device company developing in-office products for reproductive health, including cervical and uterine diagnostics. Smaller, emerging direct peer in the same gynecologic screening procedure suite.
• Copan Diagnostics: Italy/US-based manufacturer of sample collection swabs, flocked brushes and transport media for clinical diagnostics and microbiology. Closest direct peer in disposable cell/sample collection devices for diagnostic workflows.
• Puritan Medical Products: US manufacturer of single-use specimen collection devices (swabs, brushes, transport systems) for diagnostic and forensic applications. Comparable in product category and customer base.
• Greiner Bio-One: Manufacturer of pre-analytical and sample collection products (vacuum tubes, swabs, cyto brushes) for clinical laboratories and diagnostics. Overlaps with Rovers on disposable cervical and specimen-collection consumables.
• Medical Wire & Equipment (MWE): UK manufacturer of specialist swabs, collection and bacteriological sampling devices used in clinical diagnostics and laboratory workflows. Direct peer in disposable sample-collection consumables.

Emerging players

• Daye: UK-based consumer health startup offering at-home HPV/cervical screening kits and vaginal health diagnostics. Emerging direct competitor in the DTC and self-sampling segment Rovers leads clinically.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rovers-medical-devices-b.v.

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rovers Medical Devices